abstract
Influenza atau flu merupakan penyakit pernafasan akut yang disebabkan oleh bermacam virus influenza yang menginfeksi saluran pernafasan bagian atas maupun saluran pernafasan bagian bawah serta seringkali disertai gejala sistemik seperti demam, sakit kepala dan nyeri otot. Flu dapat menular melalui udara. Flu babi adalah jenis flu yang berasal dari babi dan dapat mewabah pada kawanan ternak babi. Flu babi dapat menular ke manusia melalui kontak langsung dengan hewan babi atau lingkungan yang telah terinfeksi virus flu babi, meskipun hal ini terbilang jarang terjadi. Terdapat 3 jenis virus flu babi yaitu H1N1,H2N3 dan H1N2. Virus flu babi tipe H1N1 telah diketahui sejak tahun 1918. Infeksi virus avian influenza ditransmisikan dari satu orang ke orang lain melalui pembawa virus tertentu. Virus melekat pada sel mukosa pada saluran respirasi sebelum akhirnya menginfeksi sel tersebut. Penatalaksanaan pasien dengan H1N1 didasarkan pada komplikasi dan risiko yang mungkin terjadi. Selain itu, perlu juga ada pertimbangan mengeneai criteria klinis yang dimiliki pasien. Terapi medikamentosa diterapkan kepada pasien dengan memberikan antivirus, antibiotik dan terapi sistomatis. Tindakan pencegahan dilakukan dengan cara menghindari kontak langsung dengan hewan maupun lingkungan yang terinfeksi virus, serta melakukan profilaksis antivirus dan vaksinasi.
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Literature Review introduction
Influenza is an acute respiratory diseases caused by various influenza virus that infect the upper and lower respiratory tract and often accompanied by systemic symptoms such as fever, headache and muscle pain. Influenza spreads through the air. Several epidemical evidence of influenza cases showed high morbidity rate especially for patient with higher risk caused by pulmonary complication. 1, 2 Swine influenza comes from pig and could cause an outbreaks in pig flocks. Clinical signs of this disease are fever, appetite loss, weight loss, sluggishness, cough, sneezes, cold and asphyxiate. Pig incubation usually given in 1 to 3 days. It has low mortality rate (1% to 3%) and the infected animals are usually getting better in 5 until 7 days. Some pigs are showed a severe pneumonia symptoms as a major cause of death. Secondary bacteria infection could occurs. The process of viral internalization could be happened within 24 hours after infection and become disease after 7 to 10 days. 3, 4, 5 Animal to human swine influenza virus transmission is rarely happen. But it can be transmitted through a direct contact between infected pig and human, also by living in environment that already being contaminated with swine influenza virus under special circumstances. Once human are infected, they could transmitted the virus to one and another with the same way of influenza virus works through cough or sneeze. Avian influenza virus infection is transmitted from one person to another through secret containing virus. Virus is binded into the mucous cells of respiratory tract before it is finally infecting the cells itself. Influenza infection is occured after secret transfer in the exhalation from one to another. If it is not neutralized by antibodies, virus would strike the respiratory tract and the cells. In host cell, after cellular dysfunction and degeneeration happens, along with replication of the virus and release of viral replication. Almost all cells in the respiratory could support replication of the virus. After the virus has led to respiratory tract infections, the virus infects many cell replication and damage epithelial cilia through direct cytopatic effect or apoptosis. The amount of virus in the respiratory tract is correlated with the severity of the disease and the degree of inflammatory cytokine pro-kemokin. Increased levels of cytokines pro inflammatory such as interferon α, interleukin 6, tumor necrosis factor occur in the blood and respiratory secretions. And may contribute to systemic symptoms and fever. Duration of viral replication depend on the age and the invulnerabILIty status. Shelding usually lasting during three to five days in the adult, often reaches the second week in children, and could survive for weeks on a host immunocompromised.
clinical symptoms
After the incubation period is complete 1-5 days, the onset of disease is tend to increase rapidly were actually causing symptoms. Clinical symptoms divided into specific symptoms and non specific, based on CDC (2009) stricken with symptoms reported is: cough (98 %), febris (96%), weak (89 per cent), headache (82 %), cold (80 %), muscle pain (80 %), nausea (55 %), abdominal pain (50 %), diarrhea (48 %), shortness of (48 %), joint pains (46 %). The symptoms above are known as ILI-fever (Influenza Like Illnes) which has temperature more than 39,8 o C accompanied by one or more symptoms of cough ingest, pain on swallowing, without any causes other the influenza.
There are mild criteria (outpatient with surveillance) such as without a symptom or symptoms at least, without fever tightness, no pneumonia, no comorbid and young age. Middle criteria (isolation room) such as comorbid factor, asfixia, pneumonia, old age, pregnancy, diarrhea and vomiting. Severe criteria (ICU) such as pneumonia broad, breath failure, sepsis, shock, declining consciousness, Artery Respiratory Distress Syndrome (ARDS) and Multiple Organ Dysfunction Syndrome (MODS). 
Virology Examination
A lot of tests available to detect influenza virus. This test has different sensitivity and specificity. Including several examinations which can be seen in Table I .
Specimens can be obtained through: nasopharyngeal swab, aspirate (wash or nasal swab) swab the endotracheal lavage, bronchoalveolar lavage (BLA), combination of nasopharyngeal or oropharyngeal swab. Oropharyngeal. Tests should be done on the first week until healing (2 -3 weeks after the onset of disease). Examination of virology should be done in patients with an indication of in-patient medium and heavy. 10, 12 Hematology Examination DL examination (Hb, Platelets, leucocyte, count of leucocyte, a lymphocyte total). Other examination depends on identification, such as chemicals analysis of the blood. To remove the diagnosis of appeals examined IgG and IgM opposed to culture week and gall Salmonela thyposa.
Radiology Examination
Examination of the lateral thoracic pa and their routines; if necessary you can be intensified CT scans in accordance with the indications.
Microbiology Examination
If in thought occurring co-infection by bacteria can detect by sputurn (smear and culture), culture blood and urine based on identification.
management
Management new patients with influenza a H1N1 2009 was based on some new consideration of the degree of the sick the risk of complications and the results of laboratorium with the criteria consideration adjusted therapy the patient whether policlinic, in-patient, the icu. Almost of influenza cases caused by a new influenza virus H1N1. There is no complications, short duration and the provision of anti virus tend to be needed for the majority of patients. Zanamivir is indicated for treatment of influenza in adults and children (>5 years). The recommended dose for treatment of adults and children from the age of 5 years is two inhalations (2 × 5mg) twice daily for 5 days Table 4 . Recommendation for giving antibiotics to influenza patients Non-severe influenza-related pneumonia a. Most patients can be adequately treated with oral antibiotics b. Oral therapy with co-amoxiclav or a tetracycline is preffered c. When oral therapy is contraindicated, recommended parenteral choices include iv co-amoxiclav, or a second-or thirdgeneeration cephalosporin (cefuroxime or cefotaxime). A macrolide (erythromycin or clarithromycin) or a fluoroquinolone active against S. pneumonia and S. aureus is an alternative regimen where required, e.g. for those intolerant of penicillins. Currently, levofloxacin and moxifloxacin are the only recommended fluoroquinolones licensed in the UK.
For severe influenza-related pneumonia a. Patients with severe pneumonia should be treated immediately after diagnosis with parenteral antibiotics.
b. An iv combination od a broad-spectrum β-lactamase stable antibiotics such as co-amoxiclav or a second-geneeration (e.g. cefuroxime) or third-geneeration (e.g. cefotaxime) cephalosporin together with a macrolide (e.g. clarithromycin or erythromycin) is preffered. c. An alternative regimen includes a fluoroquinolone with enhanced activity against pneumococci together with a broad-spectrum β-lactamase stable antibiotic or a macrolide. Currently, levofloxacin is the only fluoroqionolone with an iv formulation licensed in the UK.
The management of patients are not separated from the medikamentosa therapy provision:
Antivirus
Influenza virus A H1N1 sensitive to neuraminidase inhibitor (Nals) namely oseltamivir and zanamivir, but resistant to amantadine or rimantadin. The antiviral could reduce the disease alleviate symptoms, for illness, progresivity at preventing disease and death and decrease hospitalization. Based on the research the antiviral beneficial is given the maximum 48 hours after the onset of the disease, 5 days in therapy for patient hospitalization, patients with severe infections or in ICU patients could be given more therapy. 8, 13 Recommendations given of the antiviral that is hospitalized patients with the confirmation, probable or suspect, patient has a high risk, if there are complications and patients with chronic disease.
Antibiotics
Antibiotics can be given if the result of examination positive and secondary infection symptoms is caused by bacteria. Recommendation for giving antibiotic to patients with influenza depend on British Thoracic Society (BTS) can be seen in table 2 If based on clinical and radiological, influenzathe assessment of the weight of pneumonia associated pneumonia can stamp use standard score as PSI, CRUB Table 5 Cortikosteroid Not give a corticosteroid routine in patients by a new, H1N1 influenza based on reports of Mexico granting a corticosteroid unprofitable.A corticosteroid use higher doses will cause serious side effects due to rising replication of the virus and improve the germ opportunistic infection. 11 prevention 1. Be careful when contact with persons infected who is someone who can transmit H1N1 virus days before the onset of diseases such as 1 to 7 days, and after the onset of disease (24 hours no fever). An act done is cover nose and mouth or use a mask, wash hand soap and water or alcohol in the normal time 15 until 20 seconds, eat nutritious food, less migration to the epidemic and pandemics. 2. Antiviral prophylaxis can be given to someone with the acts of close contact patients confirmation, case probable, infectious, suspect during the period of high risk patients experienced complications and health officers contact with confirmation, cases of patients probable, suspect infectious table during the period.
14 Vaccination CDC identify priority to get population main vaccination are pregnant woman, all medical society, age 25 -64 by the risk of complications and someone who care for infants under 6 months. 13 
summary
Influenza is respiratory infections caused by influenza virus a subtype H1NI. Virus H1N1 could cause a new transmission between humans. It is because a mutation in the virus.Virus H1N1 influenza totally different with the H1N1 virus seasonal.Known for its clinical symptoms Influenza Like Illness (ILI) WHO clinically divide light being, weight. Management patients with the H1N1 influenza a new year, in some degree was based on the consideration of the complications and the risk of a laboratory. Consideration also according to this criteria of patients are policlinic, inpatient, icu. Therapy medikamentosa be granted antiviral, antibiotics and therapy symtomatic. Prevention is to avoid contact with an infected, the antiviral prophylaxis, and vaccination. 
